High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy

被引:49
|
作者
Liu, Furong [1 ,2 ]
Zhang, Yaojun [1 ,2 ]
Peng, Zhenwei [1 ,2 ]
Gao, Hengjun [1 ,2 ]
Xu, Li [1 ,2 ]
Chen, Minshan [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510060, Guangdong, Peoples R China
[2] State Key Lab Oncol So China, Guangzhou 510060, Guangdong, Peoples R China
关键词
High mobility group box 1; Hepatocellular carcinoma; Hepatectomy; Prognosis; Prognostic factor; PROTEIN HMGB1; CLINICOPATHOLOGICAL FEATURES; CELL INVASION; TUMOR-CELLS; NUCLEAR; RELEASE; RAGE; PHOSPHORYLATION; KNOCKDOWN; ALPHA;
D O I
10.1186/1479-5876-10-135
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: High mobility group box 1(HMGB1) overexpression has been reported in a variety of human cancers. However, the role of HMGB1 in hepatocellular carcinoma (HCC) remains unclear. The aim of present study was to analyze HMGB1 protein expression in tumor, para-tumor and normal tissue and to assess its prognostic significance for HCC after curative hepatectomy. Methods: The levels of HMGB1 mRNA and protein in tumor, para-tumor and normal tissue were evaluated in 11 HCC cases by Reverse Transcription-polymerase chain reaction (RT-PCR) and Western blot. Additionally, HMGB1 protein expression in 161 HCC was analyzed by immunohistochemistry and correlated with clinicopathological characteristics and survivals. Student's t-test, spearman's rank correlation, Kaplan-Meier plots and Cox proportional hazards regression model were used to analyze the data. Results: By RT-PCR and Western blot, the levels of HMGB1 mRNA and protein were significantly higher in HCC, compared to that in para-tumor (p<0.001) and normal tissue (p<0.001). Immunohistochemical staining revealed that high expression of HMGB1 was detected in 42.9% (69/161) HCC cases. High expression of HMGB1 was significantly associated with incomplete encapsulation (p = 0.035) and advanced TNM stage (p = 0.036). Multivariate analysis showed that high expression of HMGB1 was an independent prognostic factor for both overall (p = 0.009, HR = 1.834, 95% CI: 1.167-2.881) and disease-free survival (p = 0.018, HR = 1.622, 95% CI: 1.088-2.419), along with tumor size. Subgroup analysis revealed that high expression of HMGB1 predicted poorer overall survival only for tumor >5 cm (p = 0.031), but not for tumor <= 5 cm (p = 0.101). Conclusions: HMGB1 protein might contribute to the malignant progression of HCC, high expression of HMGB1 predicts poor prognosis for patients with HCC after curative hepatectomy, especially for patients with tumor >5 cm.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
    Suren, Dinc
    Yildirim, Mustafa
    Demirpence, Ozlem
    Kaya, Vildan
    Alikanoglu, Arsenal Sezgin
    Bulbuller, Nurullah
    Yildiz, Mustafa
    Sezer, Cem
    MEDICAL SCIENCE MONITOR, 2014, 20 : 530 - 537
  • [22] Prognostic Significance of High Mobility Group Box 1 (HMGB1) Expression in Patients with Colorectal Cancer
    Ueda, Masami
    Takahashi, Yusuke
    Shinden, Yoshiaki
    Sakimura, Shotaro
    Hirata, Hidenari
    Uchi, Ryutaro
    Takano, Yuki
    Kurashige, Junji
    Iguchi, Tomohiro
    Eguchi, Hidetoshi
    Sugimachi, Keishi
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    Mimori, Koshi
    ANTICANCER RESEARCH, 2014, 34 (10) : 5357 - 5362
  • [23] The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review
    Ikram, Fathimath Zaha
    Arulsamy, Alina
    Retinasamy, Thaarvena
    Shaikh, Mohd Farooq
    CURRENT NEUROPHARMACOLOGY, 2022, 20 (11) : 2221 - 2245
  • [24] Autoantibodies Against High Mobility Group Box 1 (HMGB1) in Patients with SLE
    Schaper, Fleur
    Horst, Gerda
    Henegouwen, Daan van Beijeren Bergenen
    Bijzet, Johan
    de Leeuw, Karina
    Stel, Alja
    Limburg, Pieter C.
    Heeringa, Peter
    Westra, Johanna
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S718 - S718
  • [25] High Mobility Group Box 1 (HMGB1) Phenotypic Role Revealed with Stress
    Daolin Tang
    Rui Kang
    Bennett Van Houten
    Herbert J. Zeh
    Timothy R. Billiar
    Michael T. Lotze
    Molecular Medicine, 2014, 20 : 359 - 362
  • [26] High-mobility group box 1 (HMGB1) protein: Friend and foe
    Ulloa, Luis
    Messmer, Davorka
    CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (03) : 189 - 201
  • [27] High Mobility Group Box 1 (HMGB1) Levels in the Placenta and in Serum in Preeclampsia
    Wang, Bo
    Koga, Kaori
    Osuga, Yutaka
    Hirata, Tetsuya
    Saito, Ako
    Yoshino, Osamu
    Hirota, Yasushi
    Harada, Miyuki
    Takemura, Yuri
    Fujii, Tomoyuki
    Taketani, Yuji
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 66 (02) : 143 - 148
  • [28] The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases
    Chen, Qingjie
    Guan, Xiaofeng
    Zuo, Xiaocong
    Wang, Jianglin
    Yin, Wenjun
    ACTA PHARMACEUTICA SINICA B, 2016, 6 (03) : 183 - 188
  • [29] The role of high mobility group box 1(HMGB1)in the pathogenesis of kidney diseases
    Qingjie Chen
    Xiaofeng Guan
    Xiaocong Zuo
    Jianglin Wang
    Wenjun Yin
    Acta Pharmaceutica Sinica B, 2016, 6 (03) : 183 - 188
  • [30] High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
    Yuan, Shunling
    Liu, Zhaoping
    Xu, Zhenru
    Liu, Jing
    Zhang, Ji
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)